But when it's sold to you at $14.91, is that company actually selling it at a loss, only covered by USA paying more? Or are they still making a profit, and simply selling it higher to the US, because they know the health insurance companies will just pay more because their system is messed up without proper incentives.
Here's a Google AI overview:
Price differences: The U.S. price for Wegovy can be over $1,300 per month, while the same drug may cost around $92 in the UK and even less in other countries. Studies suggest these drugs can be produced for a fraction of the U.S. price, sometimes as low as $5 a month.
Reasoning: Unlike other high-income countries, the U.S. has a system where drug prices are not subject to strict government regulation. This allows pharmaceutical companies to charge a premium in the U.S. market.
But when it's sold to you at $14.91, is that company actually selling it to you at a loss, only covered by USA paying more. Or are they still making a profit, and simply selling it higher to the US, because they know the health insurance companies will just pay more because their system is messed up without proper incentives.
Here's a Google AI overview:
Price differences: The U.S. price for Wegovy can be over $1,300 per month, while the same drug may cost around $92 in the UK and even less in other countries. Studies suggest these drugs can be produced for a fraction of the U.S. price, sometimes as low as $5 a month.
Reasoning: Unlike other high-income countries, the U.S. has a system where drug prices are not subject to strict government regulation. This allows pharmaceutical companies to charge a premium in the U.S. market.
But when it's sold to you at $14.91, is that company actually selling it to you at a loss, only covered by USA paying more. Or are they still making a profit, and simply selling it higher to the US, because they know the health insurance companies will just pay more because their system is messed up without proper incentives.
Here's a Google AI overview: Price differences: The U.S. price for Wegovy can be over $1,300 per month, while the same drug may cost around $92 in the UK and even less in other countries. Studies suggest these drugs can be produced for a fraction of the U.S. price, sometimes as low as $5 a month.
Reasoning: Unlike other high-income countries, the U.S. has a system where drug prices are not subject to strict government regulation. This allows pharmaceutical companies to charge a premium in the U.S. market.
But when it's sold to you at $14.91, is that company actually selling it to you at a loss, only covered by USA paying more. Or are they still making a profit, and simply selling it higher to the US, because they know the health insurance companies will just pay more because their system is messed up without proper incentives.